MMP-13 expression in keratocyst odontogenic tumour associated with NBCCS and sporadic keratocysts

Oral Diseases

Volumn 16, Issue 8, 2010, Pages 795-800

  Leonardi, R ^a   Matthews, J ^b   Caltabiano, R ^a   Greco, M ^a   Lombardo, C ^a   Loreto, C ^a   Santarelli, A ^c   Lo Muzio, L ^c,d  

^a UNIVERSITY OF CATANIA   (Italy)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^c UNIVERSITY OF FOGGIA   (Italy)

^d CROB (Centro di Riferimento Oncologico Basilicata)   (Italy)

Author keywords

Gorlin Gotz syndrome; MMP13; NBCCS; Odontogenic keratocysts

Indexed keywords

COLLAGENASE 3;

ANTIBODY LABELING; ARTICLE; BASAL CELL CARCINOMA; CORNEA CELL; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; ODONTOGENIC KERATOCYST; ODONTOGENIC TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION;

CARCINOMA, BASAL CELL; EPITHELIAL CELLS; EPITHELIUM; HUMANS; IMMUNOHISTOCHEMISTRY; MATRIX METALLOPROTEINASE 13; ODONTOGENIC CYSTS; ODONTOGENIC TUMORS; STROMAL CELLS;

EID: 77958189758     PISSN: 1354523X     EISSN: 16010825     Source Type: Journal    
DOI: 10.1111/j.1601-0825.2010.01690.x     Document Type: Article

References (39)

1. Barnes L, Eveson J, Reichart P, Sidransky D (2005). Pathology and genetics of head and neck tumours. In: WHO classification of tumours series. 2005 IARC Press, Lyon.
2. Cavalcante RB, Pereira KM, Nonaka CF, Nogueira RL, De Souza LB (2008). Immunohistochemical expression of MMPs 1, 7, and 26 in syndrome and nonsyndrome odontogenic keratocysts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 106: 99-105.
3. Cazorla M, Hernandez L, Nadal A et al (1998). Collagenase-3 expression is associated with advanced local invasion in human squamous cell carcinomas of the larynx. J Pathol 186: 144-150.
4. Cheng XW, Kuzuya M, Nakamura K et al (2005). Mechanisms of the inhibitory effect of epigallocatechin-3 gallate on cultured human vascular smooth muscle cell invasion. Arterioscler Thromb Vasc Biol 25: 1864-1870.
5. Dakubo GD, Mazerolle CJ, Wallace VA (2006). Expression of Notch and Wnt pathway components and activation of Notch signaling in medulloblastomas from heterozygous patched mice. J Neurooncol 79: 221-227.
6. Evans DG, Ladusans EJ, Rimmer S, Burnell LD, Thakker N, Farndon PA (1993). Complications of the naevoid basal cell carcinoma syndrome: results of a population based study. J Med Genet 30: 460-464.
7. Forssell K, Forssell H, Kahnberg KE (1988). Recurrence of keratocysts. A long-term follow-up study. Int J Oral Maxillofac Surg 17: 25-28.
8. Freije JM, Diez-Itza I, Balbin M et al (1994). Molecular cloning and expression of collagenase-3, a novel human matrix metalloproteinase produced by breast carcinomas. J Biol Chem 269: 16766-16773.
9. Ghali L, Wong ST, Green J, Tidman N, Quinn AG (1999). 'Gli1 protein is expressed in basal cell carcinomas, outer root sheath keratinocytes and a subpopulation of mesenchymal cells in normal human skin'. J Invest Dermatol 113: 595-599.
10. Gonzalez Moles MA, Mosqueda-Taylor A, Esteban F et al (2008). Cell proliferation associated with actions of the substance P/NK-1 receptor complex in keratocystic odontogenic tumours. Oral Oncol 44: 1127-1133.
11. Gorlin RJ, Goltz RW (1960). Multiple nevoid basal-cell epithelioma, jaw cysts and bifid rib. A syndrome. N Engl J Med 262: 908-912.
12. Gorlin RJ, Vickers RA, Kellen E, Williamson JJ (1965). Multiple basal-cell nevi syndrome. An analysis of a syndrome consisting of multiple nevoid basal-cell carcinoma, jaw cysts, skeletal anomalies, medulloblastoma, and hyporesponsiveness to parathormone. Cancer 18: 89-104.
13. Johansson N, Saarialho-Kere U, Airola K et al (1997). Collagenase-3 (MMP-13) is expressed by hypertrophic chondrocytes, periosteal cells, and osteoblasts during human fetal bone development. Dev Dyn 208: 387-397.
14. Katase N, Nagatsuka H, Tsujigiwa H et al (2007). Analysis of the neoplastic nature and biological potential of sporadic and nevoid basal cell carcinoma syndrome-associated keratocystic odontogenic tumor. J Oral Pathol Med 36: 550-554.
15. Kimi K, Kumamoto H, Ooya K, Motegi K (2001). Immunohistochemical analysis of cell-cycle- and apoptosis-related factors in lining epithelium of odontogenic keratocysts. J Oral Pathol Med 30: 434-442.
16. Kimonis VE, Goldstein AM, Pastakia B et al (1997). Clinical manifestations in 105 persons with nevoid basal cell carcinoma syndrome. Am J Med Genet 69: 299-308.
17. Kramer IR (1992). The World Health Organization: histological typing of odontogenic tumours: an introduction to the second edition. J Dent Assoc S Afr 47: 208-210.
18. Krecicki T, Fraczek M, Jelen M, Podhorska M, Szkudlarek T, Zatonski T (2003). Expression of collagenase-1 (MMP-1), collagenase-3 (MMP-13) and tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) in laryngeal squamous cell carcinomas. Eur Arch Otorhinolaryngol 260: 494-497.
19. Kubota Y, Oka S, Nakagawa S, Shirasuna K (2002). Interleukin-1alpha enhances type I collagen-induced activation of matrix metalloproteinase-2 in odontogenic keratocyst fibroblasts. J Dent Res 81: 23-27.
20. Leeman MF, McKay JA, Murray GI (2002). Matrix metalloproteinase 13 activity is associated with poor prognosis in colorectal cancer. J Clin Pathol 55: 758-762.
21. Leonardi R, Caltabiano R, Loreto C (2005). Collagenase-3 (MMP-13) is expressed in periapical lesions: an immunohistochemical study. Int Endod J 38: 297-301.
22. Li TJ, Browne RM, Matthews JB (1995). Epithelial cell proliferation in odontogenic keratocysts: a comparative immunocytochemical study of Ki67 in simple, recurrent and basal cell naevus syndrome (BCNS)-associated lesions. J Oral Pathol Med 24: 221-226.
23. Llano E, Pendas AM, Knauper V et al (1997). Identification and structural and functional characterization of human enamelysin (MMP-20). Biochemistry 36: 15101-15108.
24. Lo Muzio L, Staibano S, Pannone G et al (1999). Expression of cell cycle and apoptosis-related proteins in sporadic odontogenic keratocysts and odontogenic keratocysts associated with the nevoid basal cell carcinoma syndrome. J Dent Res 78: 1345-1353.
25. Lombardi T, Odell EW, Morgan PR (1995). p53 immunohistochemistry of odontogenic keratocysts in relation to recurrence, basal-cell budding and basal-cell naevus syndrome. Arch Oral Biol 40: 1081-1084.
26. Lynch CC, Matrisian LM (2002). Matrix metalloproteinases in tumor-host cell communication. Differentiation 70: 561-573.
27. Madras J, Lapointe H (2008). Keratocystic odontogenic tumour: reclassification of the odontogenic keratocyst from cyst to tumour. J Can Dent Assoc 74: 165-165h.
28. Majmudar G, Nelson BR, Jensen TC, Johnson TM (1994). Increased expression of matrix metalloproteinase-3 (stromelysin-1) in cultured fibroblasts and basal cell carcinomas of nevoid basal cell carcinoma syndrome. Mol Carcinog 11: 29-33.
29. Meara JG, Pilch BZ, Shah SS, Cunningham MJ (2000). Cytokeratin expression in the odontogenic keratocyst. J Oral Maxillofac Surg 58: 862-865.
30. Mueller MM, Fusenig NE (2002). Tumor-stroma interactions directing phenotype and progression of epithelial skin tumor cells. Differentiation 70: 486-497.
31. Nabeshima K, Inoue T, Shimao Y, Sameshima T (2002). Matrix metalloproteinases in tumor invasion: role for cell migration. Pathol Int 52: 255-264.
32. Nielsen BS, Rank F, Lopez JM et al (2001). Collagenase-3 expression in breast myofibroblasts as a molecular marker of transition of ductal carcinoma in situ lesions to invasive ductal carcinomas. Cancer Res 61: 7091-7100.
33. Ogden GR, Chisholm DM, Kiddie RA, Lane DP (1992). p53 protein in odontogenic cysts: increased expression in some odontogenic keratocysts. J Clin Pathol 45: 1007-1010.
34. Oka S, Kubota Y, Yamashiro T et al (2005). Effects of positive pressure in odontogenic keratocysts. J Dent Res 84: 913-918.
35. De Paula AM, Carvalhais JN, Domingues MG, Barreto DC, Mesquita RA (2000). Cell proliferation markers in the odontogenic keratocyst: effect of inflammation. J Oral Pathol Med 29: 477-482.
36. Shear M (2002a). The aggressive nature of the odontogenic keratocyst: is it a benign cystic neoplasm? Part 1. Clinical and early experimental evidence of aggressive behaviour Oral Oncol 38: 219-226.
37. Shear M (2002b). The aggressive nature of the odontogenic keratocyst: is it a benign cystic neoplasm? Part 2. Proliferation and genetic studies Oral Oncol 38: 323-331.
38. Wahlgren J, Vaananen A, Teronen O et al (2003). Laminin-5 gamma 2 chain is colocalized with gelatinase-A (MMP-2) and collagenase-3 (MMP-13) in odontogenic keratocysts. J Oral Pathol Med 32: 100-107.
39. Zedan W, Robinson PA, Markham AF, High AS (2001). Expression of the Sonic Hedgehog receptor 'PATCHED' in basal cell carcinomas and odontogenic keratocysts. J Pathol 194: 473-477.